Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results
Ridgetech, Inc. announced its financial results for the fiscal year ended March 31, 2026. The company, a wholesale distributor of pharmaceutical and healthcare products in China, reported an increase in revenue and profit.
HANGZHOU, China – Ridgetech, Inc. (Nasdaq: RDGT) today announced its financial results for the fiscal year ended March 31, 2026. The company, which operates as a wholesale distributor of pharmaceutical and healthcare products in China, reported an increase in revenue and profit for the period.
For the fiscal year 2026, Ridgetech's revenue grew by X percent to Y euros compared to the previous year. Net income was Z euros, a significant improvement from the net loss reported in the prior fiscal year. CEO Frank Zhao cited a recovery in demand and the company's expanded product offerings as key drivers for the growth.
In recent years, the company has focused on enhancing its distribution network and developing its digital services. These initiatives appear to be yielding positive results, allowing Ridgetech to strengthen its position within the Chinese healthcare market.
Furthermore, the company indicated in its release that it is considering strategic partnerships for the distribution of new healthcare technologies. Looking ahead to the next fiscal year, Ridgetech anticipates moderate but steady growth.